TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36154808

Group type: EXPERIMENTAL
Intervention: Early Dorsal Venous Complex (DVC) ligation
Number of subjects: 261

Group type: COMPARATOR
Intervention: Standard technique (Control)
Number of subjects: 261
Study: 33396889

Group type: COMPARATOR
Intervention: NORM-EX
Number of subjects: 57
Study: 32965160

Group type: EXPERIMENTAL
Intervention: Sinusoidal linear accelerations ranging from 0.03 Hz at 0.5 mG to 0.2 Hz at 5 mG
Number of subjects: 0
Study: 33185243

Group type: COMPARATOR
Intervention: Retrograde LV access
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Transseptal LV access
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Overall population
Number of subjects: 144
Study: 36243174

Group type: EXPERIMENTAL
Intervention: Eye-tracking during hand hygiene tasks
Number of subjects: 49
Study: 33398587

Group type: EXPERIMENTAL
Intervention: Procedural VR training
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Basic VR training
Number of subjects: 26

Group type: COMPARATOR
Intervention: No training (control)
Number of subjects: 26
Study: 33350787

Group type: EXPERIMENTAL
Intervention: ASF (a Compound of Traditional Chinese Medicine)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study: 34351816

Group type: EXPERIMENTAL
Intervention: Endurance exercise (EE), 45 minutes cycling at 70% of estimated V̇O2max
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Resistance exercise (RE), 4 sets of 7RM, leg press and knee extension
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 30
Study: 32114479

Group type: EXPERIMENTAL
Intervention: iMove exercise intervention (12-week semi-supervised exercise programme)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Usual care (information booklet about exercise for people with cancer)
Number of subjects: 30
Study: 32075607

Group type: EXPERIMENTAL
Intervention: Intervention delivered by trained schoolteachers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intervention delivered by nutrition professionals
Number of subjects: 0
Study: 34182873

Group type: EXPERIMENTAL
Intervention: Vaginal progesterone (200 mg daily from 16 to 33 weeks of gestation)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Vaginal progesterone
Number of subjects: 119
Study: 35358063

Group type: EXPERIMENTAL
Intervention: Gabapentin (50 mg/kg)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 33661018

Group type: EXPERIMENTAL
Intervention: STEPPS (group psychotherapy approach)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 118
Study: 33279786

Group type: EXPERIMENTAL
Intervention: Writing a letter expressing appreciation for friend's body functionality
Number of subjects: 154

Group type: COMPARATOR
Intervention: Writing a letter expressing appreciation for shared memories
Number of subjects: 154
Study: 35996884

Group type: EXPERIMENTAL
Intervention: Meditation intervention
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural intervention
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Informational intervention
Number of subjects: 95

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 95
Study: 33218742

Group type: EXPERIMENTAL
Intervention: Naltrexone + Bupropion (NB) 50/300 mg
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Naltrexone + Bupropion (NB)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Naltrexone + Bupropion (NB) and Placebo
Number of subjects: 22
Study: 32051189

Group type: EXPERIMENTAL
Intervention: Dengue virus infection
Number of subjects: 12573

Group type: COMPARATOR
Intervention: Non-dengue controls
Number of subjects: 12573
Study: 35556946

Group type: EXPERIMENTAL
Intervention: MitoQ (100 - 160 mg based on body mass)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15

Group type: COMPARATOR
Intervention: YKL-40 (Placebo: 607 ± 386 vs MitoQ 448 ± 241 pg/min, p = 0.544)
Number of subjects: 15

Group type: COMPARATOR
Intervention: KIM-1 (Placebo: 79.01 ± 38.14 vs MitoQ 69.72 ± 44.26 pg/min, p = 0.362)
Number of subjects: 15

Group type: COMPARATOR
Intervention: NGAL (Placebo: 20.8 ± 16.8 vs MitoQ 18.9 ± 21.3 ng/min, p = 0.470)
Number of subjects: 15
Study: 32526235

Group type: EXPERIMENTAL
Intervention: Franseen needle
Number of subjects: 134

Group type: COMPARATOR
Intervention: Fork-tip needle
Number of subjects: 134
Study: 33639922

Group type: EXPERIMENTAL
Intervention: Yoga intervention (tailored group classes twice a week for 16 weeks)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control intervention (set activity goals with a research officer and received eight progress calls)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Yoga intervention
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control intervention
Number of subjects: 24
Study: 32325490

Group type: EXPERIMENTAL
Intervention: D-RVd
Number of subjects: 207

Group type: COMPARATOR
Intervention: RVd
Number of subjects: 207
Study: 32098633

Group type: EXPERIMENTAL
Intervention: Tailored, interactive online safety and health intervention (iCAN Plan 4 Safety)
Number of subjects: 462

Group type: COMPARATOR
Intervention: Static, non‐tailored version of the tool
Number of subjects: 462
Study: 34303381

Group type: EXPERIMENTAL
Intervention: Early care therapeutic education and psychological intervention program
Number of subjects: 84

Group type: COMPARATOR
Intervention: Standard-of-care
Number of subjects: 84
Study: 33123119

Group type: EXPERIMENTAL
Intervention: Pandemic adjuvanted vaccine
Number of subjects: 490

Group type: EXPERIMENTAL
Intervention: One vaccination dose
Number of subjects: 490

Group type: EXPERIMENTAL
Intervention: Two vaccination doses
Number of subjects: 490

Group type: EXPERIMENTAL
Intervention: Pre-existing antibodies before vaccination
Number of subjects: 490

Group type: EXPERIMENTAL
Intervention: De novo anti-HLA antibodies
Number of subjects: 490

Group type: EXPERIMENTAL
Intervention: Graft rejection
Number of subjects: 490
Study: 35073492

Group type: EXPERIMENTAL
Intervention: Tinnitus Retraining Therapy (TRT; counseling and conventional sound generators)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Partial Tinnitus Retraining Therapy (pTRT; counseling and placebo sound generators)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Standard of Care (SOC; patient-centered counseling control)
Number of subjects: 151
Study: 34656951

Group type: EXPERIMENTAL
Intervention: Nutritional status assessed by Mini Nutritional Assessment-Short Form (MNA-SF)
Number of subjects: 604

Group type: EXPERIMENTAL
Intervention: Handgrip strength
Number of subjects: 604

Group type: EXPERIMENTAL
Intervention: SPPB total score
Number of subjects: 604

Group type: EXPERIMENTAL
Intervention: Gait speed (subtest of SPPB)
Number of subjects: 604

Group type: EXPERIMENTAL
Intervention: 5 times sit-to-stand test (subtest of SPPB)
Number of subjects: 604

Group type: EXPERIMENTAL
Intervention: Nutritional status (MNA-SF)
Number of subjects: 604

Group type: EXPERIMENTAL
Intervention: Risk of malnutrition or malnutrition (MNA-SF)
Number of subjects: 604
Study: 32131745

Group type: EXPERIMENTAL
Intervention: Village-based intervention for depression (12-week program including case management and group activities)
Number of subjects: 451

Group type: EXPERIMENTAL
Intervention: Village-based intervention for depression
Number of subjects: 451

Group type: COMPARATOR
Intervention: Standard Community Mental Health Service (CMHS) care (active control)
Number of subjects: 451
Study: 35459660

Group type: EXPERIMENTAL
Intervention: Interactive 1 hour CPD course including sex and gender considerations (n=49)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Similar CPD course without sex and gender considerations (n=78)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Adjusted for age, gender and practice settings
Number of subjects: 127
Study: 33165311

Group type: EXPERIMENTAL
Intervention: Quality tools assessing attrition, missing data, compliance, and related biases in rehabilitation trials
Number of subjects: 0

Group type: COMPARATOR
Intervention: Existing reporting guidelines (CONSORT and its extensions)
Number of subjects: 0
Study: 35366320

Group type: EXPERIMENTAL
Intervention: CRT-D
Number of subjects: 3569

Group type: COMPARATOR
Intervention: CRT-P
Number of subjects: 3569
Study: 34121308

Group type: EXPERIMENTAL
Intervention: LY2963016 insulin glargine (LY IGlar)
Number of subjects: 272

Group type: COMPARATOR
Intervention: Insulin glargine (Lantus®)
Number of subjects: 272
Study: 32643885

Group type: EXPERIMENTAL
Intervention: Baixiao moxibustion at meridian sinew nodal points combined with routine rehabilitation
Number of subjects: 50

Group type: COMPARATOR
Intervention: Routine rehabilitation training of the ipsilateral upper and lower limbs
Number of subjects: 50
Study: 35249528

Group type: EXPERIMENTAL
Intervention: Nurse-led Telephone Survivorship Clinic (TSC)
Number of subjects: 0
Study: 32179562

Group type: EXPERIMENTAL
Intervention: Montmorency tart cherry juice daily for a 12-month period
Number of subjects: 120

Group type: COMPARATOR
Intervention: Cherry-flavoured placebo drink
Number of subjects: 120
Study: 34347225

Group type: EXPERIMENTAL
Intervention: Hyperangulated McGrath X-blade (MGX)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Macintosh-type CMAC (CM) videolaryngoscope
Number of subjects: 210
Study: 33401523

Group type: EXPERIMENTAL
Intervention: EBP educational program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 35833258

Group type: EXPERIMENTAL
Intervention: JITAIs alongside 16 sessions of CBT
Number of subjects: 56

Group type: COMPARATOR
Intervention: No JITAIs alongside 16 sessions of CBT
Number of subjects: 56
Study: 34469795

Group type: EXPERIMENTAL
Intervention: 6% HP + LED/laser
Number of subjects: 20

Group type: COMPARATOR
Intervention: 6% HP
Number of subjects: 20
Study: 32403118

Group type: EXPERIMENTAL
Intervention: POMA 320 mg/d
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: POMA 80 mg/d
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: TS-134 20 mg/d
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: TS-134 60 mg/d
Number of subjects: 158

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 158
Study: 35195704

Group type: EXPERIMENTAL
Intervention: Food labels & real-time feedback
Number of subjects: 756

Group type: EXPERIMENTAL
Intervention: Ordering products by nutritional quality score
Number of subjects: 756

Group type: COMPARATOR
Intervention: Tax
Number of subjects: 756

Group type: COMPARATOR
Intervention: Healthier substitute offers
Number of subjects: 756
Study: 34307079

Group type: EXPERIMENTAL
Intervention: PROB 3 (3 ml of probiotic)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: AGP (300 ppm zinc bacitracin)
Number of subjects: 50

Group type: COMPARATOR
Intervention: CONTROL (without probiotic)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: PROB 2 (2 ml of probiotic)
Number of subjects: 50
Study: 32217809

Group type: EXPERIMENTAL
Intervention: Pasireotide 40 or 60 mg
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Pasireotide 60 mg (for uncontrolled patients)
Number of subjects: 173

Group type: COMPARATOR
Intervention: Active control (octreotide/lanreotide)
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Pasireotide (core + extension)
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Crossover group (from active control to pasireotide)
Number of subjects: 173
Study: 33882710

Group type: EXPERIMENTAL
Intervention: Attachment and Biobehavioral Catch-up intervention (ABC)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Control intervention
Number of subjects: 122
Study: 32185729

Group type: EXPERIMENTAL
Intervention: VisuEvo® (self-administered three times daily for the whole study duration)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (no tear substitute administration)
Number of subjects: 45
Study: 33581821

Group type: EXPERIMENTAL
Intervention: Cemiplimab 350 mg every 3 weeks
Number of subjects: 710

Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 710
Study: 33091202

Group type: EXPERIMENTAL
Intervention: 1.8% liposomal TA twice daily
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Microneedling with 5% TA solution weekly
Number of subjects: 60

Group type: COMPARATOR
Intervention: 2% hydroquinone every night
Number of subjects: 60
Study: 36000999

Group type: EXPERIMENTAL
Intervention: Scaling and root planning (SRP)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Tooth brushing
Number of subjects: 40
Study: 34678908

Group type: EXPERIMENTAL
Intervention: Shenfu injection (SFI) + azithromycin + 100 mL 5% glucose injection
Number of subjects: 0

Group type: COMPARATOR
Intervention: azithromycin + 150 mL 5% glucose injection
Number of subjects: 0
Study: 32747522

Group type: EXPERIMENTAL
Intervention: Fremanezumab quarterly (675 mg at baseline, placebo at weeks 4 and 8)
Number of subjects: 1121

Group type: EXPERIMENTAL
Intervention: Fremanezumab monthly (225 mg at baseline, weeks 4 and 8)
Number of subjects: 1121

Group type: EXPERIMENTAL
Intervention: Fremanezumab quarterly or monthly
Number of subjects: 1121

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1121
Study: 36150707

Group type: COMPARATOR
Intervention: High-effort group (HI)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Low-effort group (LO)
Number of subjects: 68
Study: 33530930

Group type: EXPERIMENTAL
Intervention: PATH approach to advance care planning (ACP)
Number of subjects: 314
Study: 32825830

Group type: EXPERIMENTAL
Intervention: Social support at one month after childbirth
Number of subjects: 405

Group type: EXPERIMENTAL
Intervention: Negative social interactions one month after childbirth
Number of subjects: 405
Study: 35865278

Group type: EXPERIMENTAL
Intervention: Raising Our Spirits Together (ROST), a technology‐assisted cognitive behavioral therapy (T‐CBT) for depression, delivered virtually in a small group format across 8 weekly sessions via videoconferencing software.
Number of subjects: 84

Group type: COMPARATOR
Intervention: Enhanced control condition
Number of subjects: 84
Study: 33640932

Group type: EXPERIMENTAL
Intervention: 125I seed localization
Number of subjects: 659

Group type: COMPARATOR
Intervention: Hookwire localization (HWL)
Number of subjects: 659
Study: 35276897

Group type: EXPERIMENTAL
Intervention: 2 g of Medium-Chain Triglycerides (MCTs) daily for 2 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Long-Chain Triglycerides (Control)
Number of subjects: 0
Study: 33373464

Group type: EXPERIMENTAL
Intervention: Ibuprofen (600 mg 3 times daily for 3 days, then placebo for 4 days)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Ibuprofen (3 times daily for 7 days)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo (for 7 days)
Number of subjects: 96
Study: 32831133

Group type: EXPERIMENTAL
Intervention: Adjunct therapeutic plasma exchange (TPE)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 80
Study: 35055542

Group type: EXPERIMENTAL
Intervention: Online Problem-Based Learning (PBL) intervention
Number of subjects: 100

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 100

Group type: COMPARATOR
Intervention: Both intervention and waitlist control groups
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 100
Study: 35005191

Group type: EXPERIMENTAL
Intervention: Web-based intervention (assessment of drinking behavior, personalized normative feedback, psychoeducation, short quiz)
Number of subjects: 546
Study: 32567124

Group type: EXPERIMENTAL
Intervention: Oral PALO 0.50 mg
Number of subjects: 320

Group type: COMPARATOR
Intervention: IV PALO 0.25 mg
Number of subjects: 320
Study: 36109791

Group type: EXPERIMENTAL
Intervention: Carrageenan nasal and throat spray (1.2 mg iota-carrageenan, 0.4 mg kappa-carrageenan, 0.5% sodium chloride) applied daily for 8 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (0.5% sodium chloride) applied daily for 8 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Carrageenan nasal and throat spray
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (0.5% sodium chloride)
Number of subjects: 0
Study: 33069664

Group type: EXPERIMENTAL
Intervention: 80 mg caffeine
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Caffeine dose > 1.3 mg/kg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Caffeine
Number of subjects: 18
Study: 32905676

Group type: EXPERIMENTAL
Intervention: Darolutamide
Number of subjects: 1509

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1509
Study: 35751744

Group type: EXPERIMENTAL
Intervention: Indirect pulp treatment (IPT)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Partial pulpotomy (PP)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Cervical pulpotomy (CP)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both types of pulpotomy combined
Number of subjects: 50
Study: 32487645

Group type: EXPERIMENTAL
Intervention: Iodine uptake (IU) during staging
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Iodine uptake (IU) during follow-up
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Change in iodine uptake (IU), MTV, and TLG between timepoints
Number of subjects: 45
Study: 32213484

Group type: EXPERIMENTAL
Intervention: Self-managed, computerised speech and language therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care or attention control
Number of subjects: 0
Study: 35851035

Group type: EXPERIMENTAL
Intervention: nHF 6 L/min
Number of subjects: 120

Group type: COMPARATOR
Intervention: nCPAP alone
Number of subjects: 120
Study: 33186518

Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 66

Group type: COMPARATOR
Intervention: Dexmedetomidine
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 66
Study: 34969712

Group type: EXPERIMENTAL
Intervention: Docetaxel 75 mg/m2 for 6 cycles (Arm A)
Number of subjects: 376

Group type: COMPARATOR
Intervention: Surveillance (Arm B)
Number of subjects: 376
Study: 35047809

Group type: EXPERIMENTAL
Intervention: Surgery (open reduction and internal fixation)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Non-operative treatment (6-week cast immobilization)
Number of subjects: 126
Study: 35904496

Group type: EXPERIMENTAL
Intervention: Offer of a bandage
Number of subjects: 965

Group type: COMPARATOR
Intervention: Rigid immobilisation
Number of subjects: 965
Study: 36219303

Group type: EXPERIMENTAL
Intervention: Self-monitoring plus self-titration of antihypertensive medication
Number of subjects: 312

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 312
Study: 32401557

Group type: EXPERIMENTAL
Intervention: Supportive Parenting for Anxious Childhood Emotions (SPACE)
Number of subjects: 104

Group type: COMPARATOR
Intervention: individual child-focused cognitive behavioral therapy (CBT)
Number of subjects: 104
Study: 36450540

Group type: EXPERIMENTAL
Intervention: Agent balloon coated with a low-dose formulation of paclitaxel (2 μg/mm2)
Number of subjects: 150

Group type: COMPARATOR
Intervention: SeQuent Please paclitaxel-coated balloon (3 μg/mm2)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Agent in ISR substudy
Number of subjects: 150
Study: 34269267

Group type: EXPERIMENTAL
Intervention: THRIVE (Transnasal Humidified Rapid Insufflation Ventilatory Exchange)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional nasal cannula
Number of subjects: 60
Study: 32147536

Group type: EXPERIMENTAL
Intervention: hFCSCs
Number of subjects: 0

Group type: COMPARATOR
Intervention: SOX9 shRNA interference
Number of subjects: 0

Group type: COMPARATOR
Intervention: SOX9 expression
Number of subjects: 0
Study: 34328050

Group type: EXPERIMENTAL
Intervention: Structured CA training
Number of subjects: 39
Study: 33709942

Group type: EXPERIMENTAL
Intervention: Electronic screening with integrated feedback
Number of subjects: 300

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 300
Study: 33685686

Group type: EXPERIMENTAL
Intervention: High Protein High Starch (HPHS)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: High Starch (HS)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: High Protein (HP)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Low Protein Low Starch (LPLS)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Low Protein High Starch (LPHS)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: High Protein Low Starch (HPLS)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Low Starch (LS)
Number of subjects: 16
Study: 33151986

Group type: EXPERIMENTAL
Intervention: Systemic lipopolysaccharide (1 ng/kg) combined with 36‐hour fast and bed rest (CAT)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Overnight fast (CTR)
Number of subjects: 6
Study: 37702364

Group type: EXPERIMENTAL
Intervention: Online mindfulness training (MT) course for 4 weeks
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control group (Group B) received the same MT course after the first group
Number of subjects: 53
Study: 35976753

Group type: EXPERIMENTAL
Intervention: Kinesiology tape application after tooth extraction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cryotherapy (ice pack and intermittent cryotherapy within 24 h of operation)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No additional intervention (control group)
Number of subjects: 0
Study: 33162198

Group type: EXPERIMENTAL
Intervention: Treatment group with identifiable victim message
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Treatment group with exponential transmission message
Number of subjects: 500

Group type: COMPARATOR
Intervention: Control group with standard poster message
Number of subjects: 500
Study: 36174257

Group type: EXPERIMENTAL
Intervention: Multi-function swing suspension training program (MFSST)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 47
Study: 34118136

Group type: EXPERIMENTAL
Intervention: Endoscopic ultrasound-guided antegrade covered stent placement with long duodenal extension (EASL)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: EASL
Number of subjects: 25

Group type: COMPARATOR
Intervention: Conventional EUS-BD
Number of subjects: 25
Study: 32325419

Group type: EXPERIMENTAL
Intervention: Tecemotide (L-BLP25) added to standard-of-care treatment
Number of subjects: 400

Group type: COMPARATOR
Intervention: Standard-of-care treatment alone
Number of subjects: 400
Study: 35551065

Group type: EXPERIMENTAL
Intervention: WebParC access plus standard care
Number of subjects: 203

Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 203
Study: 33150409

Group type: EXPERIMENTAL
Intervention: 50% of body height (d50%)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Self-selected distance (dss)
Number of subjects: 70